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The therapeutic management decision-making process for breast cancer is complex, 
and is influenced by multiple factors including patient age, comorbidities, ethnicity, 
education, and availability of immediate or delayed reconstruction options. Our study 
analysed 276 patients diagnosed with breast cancer in the “Colțea” Clinical Hospital 
between 2014 and 2015. Mean patients age was 61.24, median 62, with a range of 31 to 89 
years. Younger age was associated with a less advanced local disease and younger patients 
were more likely to choose and benefit from conservative surgery.  
Most patients (61.76%) came from rural areas. Place of origin had a significant 
influence on the tumor size at the time of diagnosis (3.9 cm vs. 1.8cm) as well as on the 
choice of surgical procedure. Personalized treatment management plans that include 
aesthetic satisfaction coupled with oncological safety should be the objectives of 
contemporary breast surgery. Patient age is so important to the decision making process that 
it has been proposed as a determinant of educational and counselling strategies.  
From our experience, young patients from urban areas were more proactive patients. 
They were diagnosed earlier and more involved in treatment decisions compared with 
patients from rural areas, who generally did not question the surgeon’s opinion. Factors that 
influence the decision-making process likely include age, socioeconomic status, availability 
of radiotherapy, the necessity of periodic follow-up and the concern about recurrence.  
 
 
Acne conglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones, 
papules, pustules, nodules and sometimes hematic or meliceric crusts, located on the face, trunk, neck, arms 
and buttocks.  
 
Case Report 
We report the case of a 16 year old Caucasian female patient from the urban area who addressed our 
dermatology department for erythematous, edematous plaques covered by pustules and crusts, located on the 




Breast cancer is the most frequent cancer in women 
and a common cause of death in women diagnosed with 
cancer, with over 500,000 deaths annually (1). 
Chemoprophylaxis of atypical proliferative lesions may 
prevent cancer development for select cases and early 
detection and multimodality treatment improve survival 
and increase quality of life (2). 
Breast cancer diagnosis, represented by the period 
between breast biopsy and histopathological result, is 
described as the most distressing moment for a woman 
across the entire cancer experience (3). Anxiety 
increases over this time period and is quickly replaced 
by shock and doubt when the doctor communicates the 
diagnosis. After diagnosis, patients with breast cancer 
must face decisions about their available treatment 
options, with each having its own risks and benefits. The 
decision-making process is complex, and is influenced 
by multiple factors including patient age, comorbidities, 
ethnicity, education, and availability of immediate or 
delayed reconstruction options.     
In the past ten years women have changed from the 
passive patient who accepted whatever treatment the 
doctor prescribed to an active and informed patient who 
wants to decide which option is best (4). Personalized 
treatment management plans that include aesthetic 
satisfaction of breast cancer patients coupled with 
oncological safety should be the objectives of modern 
breast surgery. The treatment choice depends on patient 
characteristics and will, but is influenced by the doctor 
who presents and explains surgical options. In 
understanding these factors, practitioners can help 
patients make better informed and suitable decisions.  
This study is a retrospective analysis over a 2 year-
period of treatment selection by cancer patients in an 
attempt to reveal factors that influenced the decision. 
Materials and methods 
Our study analyzed 276 patients diagnosed with 
breast cancer in the “Colțea” Clinical Hospital between 
2014 and 2015. This retrospective analysis used a 
timeframe sufficiently large to ensure enough patients 
for adequate statistical power. To generate patient 
groups we utilized queried databases used for reporting 
in the DRG system (Diagnosis Related Groups), a 
classification system based on diagnosis. This system is 
similar to the international disease classification system 
(International Classification of Diseases – ICD) in which 
diagnoses are classified into classes and subclasses. 
Repeated hospitalizations were queried regarding patient 
diagnoses, along with procedures performed on these 
occasions. These tools were useful for tracking and 
monitoring patients, though with the limitation that 
patients had to have been admitted to the same medical 
institution for inclusion.  
Breast surgical procedures were divided into two 
classes:  mastectomies and conservative procedures. 
Conservative surgery included all procedures that 
partially spared the breast, such as sectorectomy, 
quadranectomy, or atypical oncoplastic resections. 
Mastectomies included variations that preserve the skin 
or the nipple-areolar complex (skin sparing, nipple 
sparing), but with total excision of the mammary gland. 
Patients were excluded if their data was incomplete 
and not sufficiently specific, or in cases where we could 
not register the result of the histopathologic examination, 
history of prior radiation to the breast area, cases of 
inflammatory breast cancer, local advanced breast 
cancer, particular histopathological types (lymphoma, 
sarcoma) which require a different therapeutic approach, 
multicentric tumors involving 2 or more breast 
quadrants, or diffuse malignant micro-calcifications and 
neoadjuvant chemotherapy. 
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Using the aforementioned exclusion criteria, we 
selected a group of 102 patients who had been potential 
candidates for both conservative and radical surgical 
treatment.    
Surgical treatment options consisted of breast 
conservative surgery (sectorectomy), oncoplastic 
technique (depending on localization and tumor/breast 
volume), skin sparring mastectomy, or classical 
mastectomy. At the time of surgery, immediate breast 
reconstruction was not possible. Delayed breast 
reconstruction was proposed along with an explanation 
of its advantages and disadvantages. 
 
Results 
Mean patients age was 61.24, median 62, with the 
youngest 31 and the oldest 88 years old. Younger age 
was associated with a less advanced local disease, and 
younger patients were more likely to benefit from 
conservative surgery (Figures 1-6). 
 
 
Figure 1. Age distribution 
Most patients (61,76%) came from rural areas. Place 
of origin had a significant influence on tumor size at the 
time of the diagnosis (3.9 cm vs 1.8cm) and on the 




A high percentage of women who underwent breast 
conservative surgery in our clinic were from urban areas.  
 
 
Figure 2. Minimal, maximal, mean and median age 
 
Figure 3. Provenance 
 









Figure 5. Mastectomy Age 
 
Figure 6. Mastectomy Provenance 
 
Discussion  
After the initial shock of a breast cancer diagnosis, 
women begin to turn their attention to treatment options. 
They typically seek information about the best physician 
and treatment as well as their reconstruction options. 
Personalized treatment management plans that include 
aesthetic satisfaction coupled with oncological safety 
should be the objectives of modern breast surgery (5). 
Patient age is so important in the decision making 
process that it has been proposed as a primary 
determinant of educational and counseling strategies (3, 
5). Depending on their age, women react differently 
when diagnosed with breast cancer, choosing also a 
distinct type of treatment. Young women under 30 may 
be considering a family and children, and how a cancer 
diagnosis might affect this future prospect. Women in 
the 30’s usually already have a family and are concerned 
about their future with their children and how their 
husband will support them. Women in their 40’s have 
greater family responsibilities, and a cancer diagnosis 
can upset the balance, considering that their appearance 
may affect their relationship with their husband and 
children.  Women older than 50 might have had a similar 
experience with a relative or friend and are often more 
adapted. They are typically concerned about losing their 
independence and being obliged to ask for help.    
Usually young women take an active role in 
understanding their condition, seeking information and 
becoming involved in treatment decisions, compared 
with older women who rely heavily on the surgeon’s 
recommendation (6).  Women that assume a more active 
role in their treatment suffer less from depression and are 
more satisfied with treatment outcome (7).  
In the shared decision making model, the doctor 
informs the patient about the therapy modalities and 
incorporates the patient’s needs and desire into the 
treatment decision. This model is considered best when 
treatment decisions involve multiple options (8), 
especially in the management of primary breast cancer 
where several different surgical options may result in the 
same oncologic outcome.  
From our experience, young patients from urban 
areas were the most active patients. Not only were they 
diagnosed earlier in the disease progression, but they 
were more involved in their treatment decision than 
patients from rural areas, who were more apt to accept 
the surgeon’s opinion without further questions. 
Breast cancer treatment varies from breast 
conservation to oncoplastic surgery and mastectomy, 
radiotherapy of different regimens, chemotherapy, 
Breast cancer, psychological influence and therapeutic options 
176 
 
biological and hormonal therapy, depending on the 
immunohistochemical profile.  
Socio-economic status might influence women’s 
decision-making, probably the result of greater 
information access, greater need for an aesthetically 
pleasing result, and greater access to medical services 
and expensive reconstruction procedures for those have 
greater resources (9). 
The availability of a radiotherapy facility and a high 
density of radiotherapists have been shown to influence 
treatment decisions for choosing breast conserving 
surgery over mastectomy (10, 11). However, this was 
not an influencing factor in sample as a radiotherapy unit 
was available to our patients. 
The risk of recurrence—related to tumor size, lymph 
node involvement, and stage—is an important factor 
influencing treatment decisions. Women are offered 
breast conserving surgery when faced with small tumor 
size and no detectable lymph nodes involvement (12). 
 
Conclusions 
Regarding surgical management, the most difficult 
decision a woman faces is breast conserving surgery vs. 
mastectomy. Conservative techniques, especially those 
that preserve the nipple areola complex, are followed by 
improved patient’s perception of the body image, 
confidence, and sexuality, with the only drawback being 
increased anxiety linked to recurrence risk (5). 
Even though studies have shown that, when feasible, 
breast conserving surgery associated with radiotherapy 
has a similar overall survival rate as mastectomy, 
numerous women choose mastectomy. Factors that 
influence this decision are likely age, socioeconomic 
status, the availability of radiotherapy, the necessity of 
periodic follow-up, and the concern about recurrence.  
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